... -institutional retrospective review of data from four North American academic centers – Cleveland Clinic Foundation, Memorial Sloan-Kettering Cancer Center, University of British Columbia ...
... on other treatments. The study was led by Robert Motzer, MD, an attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), who will present the findings on May 31 at the annual meeting ...
... Hudis, M.D., and Chau Dang, M.D., of Memorial Sloan-Kettering Cancer Center in New York review several trials that tested the potential benefit of adding taxanes to existing ...
... Cassileth, PhD, Chief of the Integrative Medicine Service, at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Pfister presented the findings today at the annual meeting of the ...
...
The researchers built the predictive model using data from more than 2,500 renal cancer patients in databases at Memorial Sloan-Kettering Cancer Center and the Mayo Clinic. The model is ...
... .
"He did something very different," said Samuel Danishefsky of Columbia University and the Memorial Sloan-Kettering Cancer Center, who is Coltart's former post-doctoral mentor. "You could have had ...
... , Germany; Örebro University Hospital, Sweden; Karolinska Institutet, Stockholm, Sweden; Memorial Sloan-Kettering Cancer Center; Helsinki University Central Hospital, Finland; and University Hospital ...
... Cancer Center and Research Institute in Tampa, Fla., Memorial Sloan-Kettering Cancer Center in New York, and Dana-Farber Cancer Institute in Boston.
Methodology: The researchers ...
... contradictory results. Dr. Christian Nelson, a psychologist at Memorial Sloan-Kettering Cancer Center in New York City and his colleagues recently conducted the first review of ...
... in faithful animal models," explains Dr. Pandolfi.
In the accompanying paper, Dr. Hans-Guido Wendel (Memorial Sloan Kettering Cancer Center) and colleagues present evidence that ...
... Medical Center, Harvard Medical School, Boston, and Memorial Sloan-Kettering Cancer Center, New York, report that tumor samples from patients with biopsy-accessible solid tumors of ...
... , vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center. These new findings, published in the October 1 issue of ...
... because the loss of kidney tissue affects kidney function over time. Researchers at Memorial Sloan Kettering had previously found that patients whose kidneys were completely removed were almost 12 ...
... May Increase Risk of Pancreatic Cancer Precursor Lesions in At-Risk Patients
In a separate study conducted at Memorial Sloan-Kettering Cancer Center in New York, Dr. Emmy Ludwig ...
... Graham Zauber, PhD, Associate Attending Biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center and her colleagues' findings are published in the ...
